Format

Send to

Choose Destination
Antimicrob Agents Chemother. 2015 Jul;59(7):4315-7. doi: 10.1128/AAC.00384-15. Epub 2015 Apr 20.

Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013).

Author information

1
Diagnostic Services Manitoba, Winnipeg, Manitoba, Canada University of Manitoba, Department of Medical Microbiology and Infectious Diseases, Winnipeg, Manitoba, Canada psimner1@jhmi.edu.
2
Diagnostic Services Manitoba, Winnipeg, Manitoba, Canada University of Manitoba, Department of Medical Microbiology and Infectious Diseases, Winnipeg, Manitoba, Canada.
3
University of Manitoba, Department of Medical Microbiology and Infectious Diseases, Winnipeg, Manitoba, Canada.
4
National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
5
University of Manitoba, Department of Medical Microbiology and Infectious Diseases, Winnipeg, Manitoba, Canada National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
6
Diagnostic Services Manitoba, Winnipeg, Manitoba, Canada.

Abstract

Of 1,927 Enterococcus species isolates collected across Canada from 2007 to 2013, 80 (4.2%) were identified as vancomycin-resistant enterococci (VRE). VRE infections during this time tripled in Canadian hospitals, from 1.8% to 6.0% (P = 0.03). All VRE were Enterococcus faecium, with 90% possessing vanA. The prevalence of vanB decreased from 37.5% in 2007 to 0% in 2013 (P < 0.05). The VRE were multidrug resistant, but 70.6%, 86.3%, and 100% were susceptible to doxycycline, linezolid, and daptomycin, respectively.

PMID:
25896693
PMCID:
PMC4468682
DOI:
10.1128/AAC.00384-15
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center